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Background Previous studies suggested that enlarged perivascular spaces are neuroimaging markers 
of cerebral small vessel disease. However, it is not clear whether enlarged perivascular spaces are 
associated with cognitive impairment. We aimed to determine the cross-sectional relationship 
between enlarged perivascular spaces and small vessel disease, and to investigate the relationship 
between enlarged perivascular spaces and subsequent cognitive impairment in patients with recent 
cerebral ischemic event. 
Methods Anonymized data were accessed from the virtual international stroke trial archive. We 
rated number of lacunes, white matter hyperintensities, brain atrophy, and enlarged perivascular 
spaces with validated scales on magnetic resonance brain images after the index stroke. We defined 
cognitive impairment as a mini mental state examination score of ≤26, recorded at one year post 
stroke. We examined the associations between enlarged perivascular spaces and clinical and imaging 
markers of small vessel disease at presentation and clinical evidence of cognitive impairment at one 
year using linear and logistic regression models. 
Results We analyzed data on 430 patients with mean (±SD) age 64.7 (±12.7) years, 276 (64%) males. 
In linear regression analysis, age (β = 0.24; p < 0.001), hypertension (β = 0.09; p = 0.025), and deep 
white matter hyperintensities (β = 0.31; p < 0.001) were associated with enlarged perivascular 
spaces. In logistic regression analysis, basal ganglia enlarged perivascular spaces were independently 
associated with cognitive impairment at one year after adjusting for clinical confounders (OR = 1.72, 
95% CI = 1.22–2.42) and for clinical and imaging confounders (OR = 1.54; 95% CI = 1.03–2.31). 
Conclusions Our data show that in patients with ischemic cerebral events, enlarged perivascular 
spaces are cross-sectionally associated with age, hypertension, and white matter hyperintensities 
and suggest that enlarged perivascular spaces in the basal ganglia are associated with cognitive 
impairment after one year. 
  
Introduction 
Cerebral small vessel disease (SVD) affects small arteries, capillaries, and venules in the brain.1 The 
effect of SVD on both brain vessels and parenchyma encompasses a wide range of pathologic 
processes detectable by conventional neuroimaging such as magnetic resonance (MR) and 
computed tomography (CT). Traditionally, imaging features of SVD have included lacunes, white 
matter change, brain atrophy, and microbleeds.2 There is increasing evidence that enlarged 
perivascular spaces (EPVS) may be another imaging marker of SVD.3,4 Perivascular (Virchow-Robin) 
spaces are virtual fluid-filled spaces surrounding penetrating arterioles and venules which provide a 
drainage conduit for cerebral interstitial fluid. Normally undetectable with conventional imaging, 
they become more frequent with age. EPVS can be seen on T2-weighted MRI as punctate < 2 mm 
round (if vessel perpendicular to plane of image) or linear (if vessel in the plane of the image) 
cerebrospinal fluid (CSF-isointense) lesions along the course of penetrating arteries. 
A recent study of 298 patients reported that EPVS were associated with risk factors for SVD (older 
age), also clinical manifestations of SVD (lacunar stroke subtype), and imaging manifestations of SVD 
(white matter lesions).4 However, there is scarce evidence regarding the effects of EPVS on cognitive 
status. In a hospital-based series of patients presenting with transient ischemic attack (TIA) or 
stroke, EPVS were not associated with cognitive performance in any of the cognitive domains 
investigated, although an association was seen between EPVS and other imaging markers of SVD.5 
As these findings await external validation in other cohorts, we used clinical and imaging data from 
the virtual international stroke trials archive (VISTA)6 to address two complementary research 
questions: 1. What is the relationship between EPVS and clinical and imaging markers of SVD, and 2. 
What is the relationship of EPVS with post stroke cognitive function. 
 
METHODS 
We accessed patient level data from the VISTA resource and conducted retrospective analyses. We 
included patients with ischemic stroke and TIA and accompanying MR-based neuroimaging. Ethical 
approval was not required since data were anonymous. 
Clinical variables of interest included age, sex, ethnicity, hypertension, diabetes, 
hypercholesterolemia, cigarette smoking at time of the index stroke, ischemic heart disease, atrial 
fibrillation, peripheral artery disease, depression. Functional status at time of the patient evaluation 
was assessed according to Oxford Handicap Scale (OHS).7 Definite diagnosis of either stroke or TIA 
was performed by single trial investigators on the basis of duration of symptoms and imaging 
presence of cerebral infarction. Stroke etiology has been previously classified according to Trial of 
Org 10172 (TOAST) classification8 on the basis of clinical and neuroimaging investigations. For the 
purposes of the present study, we did not cross-check the stroke etiology classifications and we 
relied on the investigators’ subtyping. According to TOAST, small artery cerebral infarction was 
diagnosed when present: (a) retained consciousness and higher cerebral function; (b) CT or MR brain 
scan that was normal or showed a subcortical or brainstem small infarct; and either (c) a classical 
lacunar syndrome or a non-classical lacunar syndrome; (d) no evidence of either cardioembolism 
and ispilateral large vessel stenosis (>50%). 
A neurologist trained in MR assessment and blinded to clinical data (FA) rated all the available scans 
(T1, T2, FLAIR sequences) for presence and severity of SVD features, according to STRIVE (STandards 
for ReportIng Vascular changes on nEuroimaging) recommendations.2 An experienced 
neuroradiologist (JMW) cross-checked a sample of the readings. Where the index infarct was too 
large to allow the rating of the SVD features, we performed the SVD ratings only in the non-affected 
hemisphere. We defined lacunes as round shaped cerebrospinal fluid isointense lesions measuring 
≤20 mm in diameter on axial section in the white matter, basal ganglia or brainstem as seen on T1, 
T2 or FLAIR sequences. We graded white matter hyperintensities as 0–3 according to Fazekas scale 
in deep and periventricular white matter.9 Brain atrophy was defined as central and cortical, and 
rated separately with a three-point scale as none, mild-moderate and severe against a reference MR 
brain template with a previously used methodology.10 EPVS were defined as ≤2 mm round or linear 
cerebrospinal fluid isointense lesions (T2 hyperintense and T1/FLAIR hypointense). As previously 
done in similar studies,3⇓–5 we rated EPVS in basal ganglia and centrum semiovale using a 5-point 
ordinal scale11 as follows: 0 = no EPVS, 1 = 1–10 EPVS, 2 = 11 to 20, EPVS, 3 = 21 to 40 EPVS, and 
4 = > 40 EPVS (Figure 1). We separately assessed EPVS in basal ganglia and centrum semiovale 
because they arise from perforating arteries from deep cerebral circulation (basal ganglia EPVS) and 
from pial cerebral circulation (centrum semiovale EPVS) and may therefore have different 
pathophysiologic processes. 
Cognitive function at baseline was not recorded routinely in the index trial source and only data on 
presence of clinical diagnosis of dementia were available. For the purposes of the present study, we 
selected patients without dementia at baseline. Cognitive function one year after stroke was 
assessed using MMSE, and we defined cognitive impairment as a score of MMSE ≤ 26.12 
Statistical analysis 
We described general characteristics of the study population using basic descriptive statistics. We 
assessed correlation (using Spearman’s rank correlation coefficient) between the site of the EPVS 
(basal ganglia and centrum semiovale) and other neuroimaging features of SVD (number of lacunes, 
ordinal gradings of white matter change and brain atrophy). 
Total EPVS were normally distributed, so we examined associations between explanatory variables 
and total EPVS using linear regression. We also tested associations with total EPVS with logistic 
regression (none or mild total EPVS = 0–2 vs. moderate to severe total EPVS = 3–8). Basal ganglia and 
centrum semiovale EPVS were not normally distributed, and so we assessed univariate and 
multivariate associations with explanatory variables dichotomizing EPVS into 0–1 vs. 2–4, replicating 
the method used in previous studies.3,4 In both multivariate models, we included as explanatory 
variables age, sex, hypertension, diabetes, lacunar stroke (according to TOAST classification), 
periventricular, and deep white matter hyperintensities, central atrophy. 
We described the distribution of MMSE according to number of EPVS in basal ganglia and centrum 
semiovale. MMSE values were skewed, we therefore analyzed differences within EPVS groups with 
Kruskal–Wallis test and preferred to use logistic regression rather than linear regression to present 
association data. 
We described univariate associations between imaging markers of SVD and cognitive impairment, 
and then created a multivariate logistic regression model exploring associations between each 
imaging marker of SVD (included EPVS in basal ganglia and centrum semiovale) and MMSE, adjusting 
for age, sex, OHS at baseline, hypertension, diabetes, and depression. 
In a second logistic regression model, we included additional explanatory variables of imaging SVD 
markers that were statistically significant (p < 0.05) in the first model, adjusting for the same clinical 
confounding factors. 
Finally, in a third model, we repeated the second logistic regression model after combining central 
and cortical atrophy single scores (global cerebral atrophy). 
Statistical analysis was carried out using SPSS for Windows (version 22.0; SPSS, Armonk NY, IBM 
Corp.). 
 
RESULTS 
A total of 430 patients with ischemic stroke or TIA had corresponding MR scans at baseline. Six scans 
were excluded from rating of any SVD marker due to poor image quality. EPVS rating was not 
possible in 17 scans because of movement artefact. Assessment of all imaging markers of SVD was 
therefore possible in 407 (95%) scans. 
Mean age (±SD) of the study population was 64.7 (±12.7) years, 276 (64%) patients were male. Less 
than a half (47%) of the population was Caucasian. Median time to baseline assessment was 44 days 
(IQR = 8–101) after the index stroke event. 
A total of 349 (81%) patients had ischemic stroke as qualifying event, of whom almost a half (48%) 
were lacunar subtype on TOAST criteria (Table 1). Included patients had modest levels of early post 
stroke disability with median OHS = 1 (IQR = 1–2) at baseline. The patients had a range of 
concomitant cardiovascular diseases, with hypertension being the most common (Table 1). 
Median EPVS in the centrum semiovale was 2 (IQR = 1–2), median EPVS in basal ganglia 1 (IQR = 1–
2). Compared to total and centrum semiovale EPVS, basal ganglia EPVS were generally more closely 
related to other imaging markers of SVD, with the strongest correlation for both periventricular and 
deep white matter hyperintensities (ρ = 0.61, p < 0.001). The weakest correlation was found 
between centrum semiovale EVPS and lacunes (ρ = 0.25, p < 0.001) (Table 2). 
EPVS as neuroimaging feature of SVD 
Our linear regression model showed that age (β = 0.24; p < 0.001), hypertension (β = 0.09; p = 0.025), 
and deep white matter hyperintensities (β = 0.31; p < 0.001) were independently associated with 
total EPVS. Logistic regression model confirmed such age (OR = 1.08; 95% CI = 1.05–1.11), 
hypertension (OR = 2.04; 95% CI = 1.17–3.57), and deep white matter hyperintensities (OR = 2.11; 
95% CI = 1.24–3.58) associations. There was a non-statistically significant trend towards a significant 
association of EPVS score with lacunar strokes (β = 0.08; p = 0.054) according to TOAST classification, 
periventricular white matter hyperintensities (β = 0.13; p = 0.087), and cortical atrophy (β = 0.10; 
p = 0.056) (Table 3). Regarding location of EPVS, in logistic regression models centrum semiovale 
EPVS (OR = 2.58; 95% CI = 1.69–3.93), periventricular (OR = 2.31; 95% CI = 1.29–4.13), and deep 
(OR = 2.24; 95% CI = 1.29–3.89) white matter hyperintensities were independently associated with 
basal ganglia EPVS; whereas age (OR = 1.05; 95% CI = 1.02–1.09), hypertension (OR = 2.00; 95% 
CI = 1.10–3.63), and basal ganglia EPVS (OR = 2.93; 95% CI = 1.78–4.81) were associated to centrum 
semiovale EPVS (Table 4). 
EPVS and cognitive impairment 
We identified 408 non-demented patients at baseline. Eight patients (2%) died within one year and 
49 (12%) patients had no MMSE data recorded at follow up; therefore, a total of 351 (86% of those 
with appropriate MR imaging) patients had MMSE available one year after the qualifying event. In 
total 137 patients (39%) had cognitive impairment as defined by our threshold of MMSE ≤ 26. We 
described the groups with and without available MMSE data, there were no obvious between group 
differences (Supplemental Table). 
MMSE scores differed according to number of EPVS, both in basal ganglia (p < 0.001) and in centrum 
semiovale (p = 0.001) (Figure 2). 
In separate logistic regression models describing associations with dichotomized MMSE at one year, 
after adjusting for clinical features, we found that white matter hyperintensities (OR = 1.36, 95% 
CI = 1.07–1.73), cortical atrophy (OR = 2.42, 95% CI = 1.39–4.22), and basal ganglia EPVS (OR = 1.72, 
95% CI = 1.22–2.42) were independently associated with MMSE ≤ 26, whereas centrum semiovale 
EPVS were not. Total EPVS number were not associated with cognitive impairment (OR = 1.18; 95% 
CI = 0.96–1.45). In further models where we included other statistically significant imaging markers 
of SVD, basal ganglia EPVS showed a consistent, strong association with cognitive impairment 
(OR = 1.59; 95% CI = 1.07–2.39). Also cortical atrophy (OR = 2.27; 95% CI = 1.25–4.11) and cerebral 
atrophy (OR = 1.48; 95% CI = 1.06–2.06) were associated with cognitive impairment, while white 
matter hyperintensities lost their association (OR = 1.01; 95% CI = 0.75–1.37) (Table 5). 
 
DISCUSSION 
We have confirmed that EPVS are consistently associated with clinical and imaging markers of SVD, 
such as age, hypertension and white matter changes. Our data add to the existing weight of 
evidence that EPVS are a imaging marker of SVD. We have found that in a population of patients 
with ischemic stroke and TIA, total EPVS were not associated with cognitive impairment, whereas 
EPVS in the basal ganglia were associated with cognitive impairment at one year. 
Our results are broadly in agreement with previous studies that have described association of EPVS 
with increasing age2⇓–4 and hypertension,2,13 both important clinical risk factors for SVD. In 
contrast to previous studies on ischemic stroke patients,3,4 we did not find a significant association 
between lacunar stroke and EPVS but this likely reflects our use of a stroke subtype classification 
which is known to suffer from imprecision, with only moderate agreement among different 
physicians.14 Furthermore, the MR assessment was blinded to clinical features, and we did not 
cross-checked the TOAST etiological subtype with the imaging features of the index event. This 
potential imprecision may have reduced our ability to detect a lacunar etiological subtype-EPVS 
association. 
Total EPVS showed significant associations with age, hypertension, and deep WMH. Interestingly, 
association between EPVS and SVD markers seemed to vary by location, with basal ganglia EPVS 
showing association with imaging markers of SVD, whereas centrum semiovale EPVS having stronger 
relation with clinical risk factors. However, the direction of the association was the same for both 
basal ganglia and centrum semiovale EPVS, although the latter was not statistically significant. A 
possible differential consequence of EPVS by location has been suggested by other groups,15 but we 
cannot draw any conclusion in this regard because of the cross-sectional design of the study. 
Other groups have studied EPVS and cognition, albeit much of the literature relates to non-stroke 
cohorts.16,17 Although we found a lack of association between total EPVS and cognition, basal 
ganglia EPVS were significantly associated with cognitive status after one year. It seemed that basal 
ganglia rather than centrum semiovale EPVS had a clinical relevance with cognition, and the 
estimation of both parameters together provided as net effect a lack of association, even though the 
direction of the association was similar. A previous study describing EPVS and cognition in stroke did 
not find the significant association that we have described for basal ganglia EPVS.5 Compared to this 
study, we had access to a larger sample size and so had greater power to detect a modest 
association. A cross-sectional study reported a statistically significant correlation between basal 
ganglia EPVS and cognition in 189 patients (of whom 77 had lacunar stroke), but the correlation was 
not confirmed after adjustment for age.18 A possible explanation could be that location of EPVS has 
diverse effects on cognition, perhaps reflecting the different pathophysiology of deep (basal ganglia 
EPVS) and pial (centrum semiovale EPVS) circulation. Other groups previously advanced this 
hypothesis regarding the different role of EPVS according to their location. For example, centrum 
semiovale EPVS rather than basal ganglia EPVS seemed to be highly prevalent in patients with 
cerebral amyloid angiopathy, supporting the role of centrum semiovale EPVS as imaging marker in 
the diagnosis of the pathology.19,20 
SVD is thought to be a key driver of vascular cognitive impairment and various imaging markers of 
SVD have been previously associated with cognitive deficits, particularly in executive function.1 For 
example, white matter changes have been associated with cognitive decline and dementia.21,22 A 
systematic review and meta-analysis suggested that cognitive impairment is common among 
patients with lacunar stroke,23 and clinically silent infarcts have been also associated with cognitive 
decline.24 Lobar microbleeds, detectable with T2* sequences are associated with executive function 
impairments.25 Our study suggests that EPVS, previously proposed as markers of SVD,3,4 could be 
added to the list of features to evaluate when investigating cognitive function. Interestingly, while 
we demonstrated that white matter changes were independently associated with cognition on crude 
analysis, after adjustment for basal ganglia EPVS and cerebral atrophy, white matter changes lost 
their association with cognition. In this regard, we could speculate that basal ganglia EPVS may 
represent a more important predictor of post stroke cognition than white matter hyperintensities. 
Our study has limitations. The major limitation is the lack of a measure of cognitive status at 
baseline, since we only had data about presence or absence of clinically detected dementia. We 
were therefore unable to fully determine the causal relationship between EPVS and cognitive status 
at one year, rather we report an association that deserve further investigation with proper study 
design. We furthermore acknowledge that evaluation of cognitive deficits should be based on a 
comprehensive assessment including a complete multi-domain neuropsychological battery. As a 
brief cognitive screening tool, MMSE is not a substitute for formal neuropsychological and clinical 
assessment, nor is particularly sensitive to the cognitive deficits seen in SVD. Nonetheless, MMSE is a 
feasible tool for detection of post stroke cognition status and is commonly used in practice as well as 
in research. Secondly, 15% of our study population had no available MMSE data. These missing data 
could bias results, although comparisons of the groups with and without MMSE data did not suggest 
fundamental differences in baseline characteristics. We acknowledge that stroke itself may affect 
cognitive status (i.e. up to a third of stroke survivors suffer from cognitive impairment), and we 
partly accounted for this adjusting for stroke severity at the time of the first clinical evaluation. 
Finally, EPVS can be found in different locations, and we did not rate EPVS in the hippocampus and 
brainstem, as some authors have previously suggested.26 Rather we chose to use a scale previously 
validated in patients with stroke and cerebral SVD.14 
Strengths of our study include access to a large study population with robust data on EPVS and SVD 
in patients with ischemic stroke and TIA. We used a highly standardized methodology, replicating 
elements of previous studies in an independent cohort. Moreover, patients included in the VISTA 
resource are drawn from a number of international trials and our results represent patients from 
different ethnicity, with diverse cardiovascular risk factor profile. 
In conclusion, we have confirmed that in patients with ischemic stroke or TIA, EPVS represent 
another neuroimaging feature of SVD, acknowledging that topographical distinctions in associations 
may occur between the site of EPVS and risk factors and imaging features of SVD. Even though total 
EPVS were not associated with cognitive impairment, we showed a meaningful association between 
EPVS in basal ganglia and cognitive impairment at one year after ischemic stroke or TIA. Since this is 
result of a retrospective analysis, it should be interpreted with caution and needs external 
validation, and our results are hypothesis generating only. This hypothesis deserves further research 
with proper study design. However, it may suggest that basal ganglia EPVS might be considered as 
unfavorable neuroimaging marker in studies that investigate cognitive function in patients with 
ischemic brain events, and should be assessed in studies investigating cognition. Together with 
evidence from studies in non-stroke patients, our results support the hypothesis that EPVS, 
particularly in basal ganglia, may have an important role in identifying patients at risk of cognitive 
impairment and dementia. 
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